FIGS, Inc. (NYSE:FIGS - Get Free Report) has been given an average recommendation of "Moderate Buy" by the eleven ratings firms that are currently covering the firm, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $18.7143.
FIGS has been the subject of several recent research reports. The Goldman Sachs Group reissued a "neutral" rating and issued a $16.00 price objective on shares of FIGS in a report on Friday, August 7th. Barclays increased their target price on shares of FIGS from $17.00 to $20.00 and gave the stock an "overweight" rating in a research report on Friday, August 7th. BTIG Research lifted their target price on shares of FIGS from $20.00 to $22.00 and gave the stock a "buy" rating in a research note on Friday, August 7th. Telsey Advisory Group lowered their price target on shares of FIGS from $17.00 to $16.00 and set a "market perform" rating on the stock in a research report on Friday, August 7th. Finally, Roth Capital reissued a "buy" rating on shares of FIGS in a research report on Friday, August 7th.
Get Our Latest Report on FIGS
FIGS Trading Down 1.0%
Shares of NYSE FIGS opened at $14.17 on Wednesday. The stock has a fifty day simple moving average of $11.30 and a two-hundred day simple moving average of $12.66. FIGS has a 1-year low of $6.49 and a 1-year high of $17.48. The firm has a market cap of $2.35 billion, a price-to-earnings ratio of 42.95 and a beta of 1.03.
FIGS (NYSE:FIGS - Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.08. FIGS had a return on equity of 12.53% and a net margin of 8.72%.The firm had revenue of $196.62 million for the quarter, compared to analyst estimates of $186.17 million. During the same period in the previous year, the company posted $0.04 earnings per share. The business's revenue was up 28.8% on a year-over-year basis. Analysts forecast that FIGS will post 0.29 EPS for the current year.
Institutional Investors Weigh In On FIGS
Hedge funds and other institutional investors have recently bought and sold shares of the business. Elevated Capital Advisors LLC bought a new position in shares of FIGS in the fourth quarter worth $45,000. Quarry LP raised its stake in shares of FIGS by 1,876.3% during the 3rd quarter. Quarry LP now owns 7,846 shares of the company's stock valued at $52,000 after purchasing an additional 7,449 shares during the period. Hudson Bay Capital Management LP bought a new stake in shares of FIGS during the 2nd quarter valued at $61,000. Walleye Capital LLC purchased a new stake in FIGS during the 2nd quarter worth about $65,000. Finally, Kemnay Advisory Services Inc. purchased a new stake in FIGS during the 4th quarter worth about $69,000. Institutional investors own 92.21% of the company's stock.
FIGS Company Profile
(
Get Free Report)
FIGS, Inc operates as a direct-to-consumer designer and retailer of medical apparel and accessories. The company offers a range of products tailored to the needs of healthcare professionals, including scrub sets, lab coats, tops, bottoms, outerwear, footwear, and performance fabrics designed for comfort, durability, and antimicrobial protection. Through its e-commerce platform and a growing network of retail stores, FIGS provides customizable uniforms and accessories with a focus on innovative materials and functional design features such as four-way stretch fabrics, moisture-wicking technology, and multiple secure pockets.
Founded in 2013 by Heather Hasson and Trina Spear, FIGS set out to disrupt the traditional medical uniform market by emphasizing both form and function.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider FIGS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and FIGS wasn't on the list.
While FIGS currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.